Copyright Reports & Markets. All rights reserved.

Global Mycoplasma Pneumoniae ELISA Kits Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Mycoplasma Pneumoniae ELISA Kits Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 IgG
    • 1.3.3 IgM
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Mycoplasma Pneumoniae ELISA Kits Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Laboratory
    • 1.4.3 Hospital
    • 1.4.4 Others
  • 1.5 Global Mycoplasma Pneumoniae ELISA Kits Market Size & Forecast
    • 1.5.1 Global Mycoplasma Pneumoniae ELISA Kits Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Mycoplasma Pneumoniae ELISA Kits Sales Quantity (2020-2031)
    • 1.5.3 Global Mycoplasma Pneumoniae ELISA Kits Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 MyBioSource
    • 2.1.1 MyBioSource Details
    • 2.1.2 MyBioSource Major Business
    • 2.1.3 MyBioSource Mycoplasma Pneumoniae ELISA Kits Product and Services
    • 2.1.4 MyBioSource Mycoplasma Pneumoniae ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 MyBioSource Recent Developments/Updates
  • 2.2 BosterBio
    • 2.2.1 BosterBio Details
    • 2.2.2 BosterBio Major Business
    • 2.2.3 BosterBio Mycoplasma Pneumoniae ELISA Kits Product and Services
    • 2.2.4 BosterBio Mycoplasma Pneumoniae ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 BosterBio Recent Developments/Updates
  • 2.3 Abcam
    • 2.3.1 Abcam Details
    • 2.3.2 Abcam Major Business
    • 2.3.3 Abcam Mycoplasma Pneumoniae ELISA Kits Product and Services
    • 2.3.4 Abcam Mycoplasma Pneumoniae ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Abcam Recent Developments/Updates
  • 2.4 Novus Biologicals
    • 2.4.1 Novus Biologicals Details
    • 2.4.2 Novus Biologicals Major Business
    • 2.4.3 Novus Biologicals Mycoplasma Pneumoniae ELISA Kits Product and Services
    • 2.4.4 Novus Biologicals Mycoplasma Pneumoniae ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Novus Biologicals Recent Developments/Updates
  • 2.5 CUSABIO Technology
    • 2.5.1 CUSABIO Technology Details
    • 2.5.2 CUSABIO Technology Major Business
    • 2.5.3 CUSABIO Technology Mycoplasma Pneumoniae ELISA Kits Product and Services
    • 2.5.4 CUSABIO Technology Mycoplasma Pneumoniae ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 CUSABIO Technology Recent Developments/Updates
  • 2.6 Creative Diagnostics
    • 2.6.1 Creative Diagnostics Details
    • 2.6.2 Creative Diagnostics Major Business
    • 2.6.3 Creative Diagnostics Mycoplasma Pneumoniae ELISA Kits Product and Services
    • 2.6.4 Creative Diagnostics Mycoplasma Pneumoniae ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Creative Diagnostics Recent Developments/Updates
  • 2.7 United States Biological
    • 2.7.1 United States Biological Details
    • 2.7.2 United States Biological Major Business
    • 2.7.3 United States Biological Mycoplasma Pneumoniae ELISA Kits Product and Services
    • 2.7.4 United States Biological Mycoplasma Pneumoniae ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 United States Biological Recent Developments/Updates
  • 2.8 Biorbyt
    • 2.8.1 Biorbyt Details
    • 2.8.2 Biorbyt Major Business
    • 2.8.3 Biorbyt Mycoplasma Pneumoniae ELISA Kits Product and Services
    • 2.8.4 Biorbyt Mycoplasma Pneumoniae ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Biorbyt Recent Developments/Updates
  • 2.9 DEMEDITEC Diagnostics
    • 2.9.1 DEMEDITEC Diagnostics Details
    • 2.9.2 DEMEDITEC Diagnostics Major Business
    • 2.9.3 DEMEDITEC Diagnostics Mycoplasma Pneumoniae ELISA Kits Product and Services
    • 2.9.4 DEMEDITEC Diagnostics Mycoplasma Pneumoniae ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 DEMEDITEC Diagnostics Recent Developments/Updates
  • 2.10 Abnova Corporation
    • 2.10.1 Abnova Corporation Details
    • 2.10.2 Abnova Corporation Major Business
    • 2.10.3 Abnova Corporation Mycoplasma Pneumoniae ELISA Kits Product and Services
    • 2.10.4 Abnova Corporation Mycoplasma Pneumoniae ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Abnova Corporation Recent Developments/Updates
  • 2.11 Abbexa
    • 2.11.1 Abbexa Details
    • 2.11.2 Abbexa Major Business
    • 2.11.3 Abbexa Mycoplasma Pneumoniae ELISA Kits Product and Services
    • 2.11.4 Abbexa Mycoplasma Pneumoniae ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Abbexa Recent Developments/Updates
  • 2.12 Creative Biolabs
    • 2.12.1 Creative Biolabs Details
    • 2.12.2 Creative Biolabs Major Business
    • 2.12.3 Creative Biolabs Mycoplasma Pneumoniae ELISA Kits Product and Services
    • 2.12.4 Creative Biolabs Mycoplasma Pneumoniae ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Creative Biolabs Recent Developments/Updates
  • 2.13 IBL
    • 2.13.1 IBL Details
    • 2.13.2 IBL Major Business
    • 2.13.3 IBL Mycoplasma Pneumoniae ELISA Kits Product and Services
    • 2.13.4 IBL Mycoplasma Pneumoniae ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 IBL Recent Developments/Updates
  • 2.14 Aviva Systems Biology
    • 2.14.1 Aviva Systems Biology Details
    • 2.14.2 Aviva Systems Biology Major Business
    • 2.14.3 Aviva Systems Biology Mycoplasma Pneumoniae ELISA Kits Product and Services
    • 2.14.4 Aviva Systems Biology Mycoplasma Pneumoniae ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Aviva Systems Biology Recent Developments/Updates
  • 2.15 American Research Products
    • 2.15.1 American Research Products Details
    • 2.15.2 American Research Products Major Business
    • 2.15.3 American Research Products Mycoplasma Pneumoniae ELISA Kits Product and Services
    • 2.15.4 American Research Products Mycoplasma Pneumoniae ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 American Research Products Recent Developments/Updates
  • 2.16 Wuhan Fine Biotech
    • 2.16.1 Wuhan Fine Biotech Details
    • 2.16.2 Wuhan Fine Biotech Major Business
    • 2.16.3 Wuhan Fine Biotech Mycoplasma Pneumoniae ELISA Kits Product and Services
    • 2.16.4 Wuhan Fine Biotech Mycoplasma Pneumoniae ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Wuhan Fine Biotech Recent Developments/Updates

3 Competitive Environment: Mycoplasma Pneumoniae ELISA Kits by Manufacturer

  • 3.1 Global Mycoplasma Pneumoniae ELISA Kits Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Mycoplasma Pneumoniae ELISA Kits Revenue by Manufacturer (2020-2025)
  • 3.3 Global Mycoplasma Pneumoniae ELISA Kits Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Mycoplasma Pneumoniae ELISA Kits by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Mycoplasma Pneumoniae ELISA Kits Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Mycoplasma Pneumoniae ELISA Kits Manufacturer Market Share in 2024
  • 3.5 Mycoplasma Pneumoniae ELISA Kits Market: Overall Company Footprint Analysis
    • 3.5.1 Mycoplasma Pneumoniae ELISA Kits Market: Region Footprint
    • 3.5.2 Mycoplasma Pneumoniae ELISA Kits Market: Company Product Type Footprint
    • 3.5.3 Mycoplasma Pneumoniae ELISA Kits Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Mycoplasma Pneumoniae ELISA Kits Market Size by Region
    • 4.1.1 Global Mycoplasma Pneumoniae ELISA Kits Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Mycoplasma Pneumoniae ELISA Kits Consumption Value by Region (2020-2031)
    • 4.1.3 Global Mycoplasma Pneumoniae ELISA Kits Average Price by Region (2020-2031)
  • 4.2 North America Mycoplasma Pneumoniae ELISA Kits Consumption Value (2020-2031)
  • 4.3 Europe Mycoplasma Pneumoniae ELISA Kits Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Mycoplasma Pneumoniae ELISA Kits Consumption Value (2020-2031)
  • 4.5 South America Mycoplasma Pneumoniae ELISA Kits Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Mycoplasma Pneumoniae ELISA Kits Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Mycoplasma Pneumoniae ELISA Kits Sales Quantity by Type (2020-2031)
  • 5.2 Global Mycoplasma Pneumoniae ELISA Kits Consumption Value by Type (2020-2031)
  • 5.3 Global Mycoplasma Pneumoniae ELISA Kits Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Mycoplasma Pneumoniae ELISA Kits Sales Quantity by Application (2020-2031)
  • 6.2 Global Mycoplasma Pneumoniae ELISA Kits Consumption Value by Application (2020-2031)
  • 6.3 Global Mycoplasma Pneumoniae ELISA Kits Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Mycoplasma Pneumoniae ELISA Kits Sales Quantity by Type (2020-2031)
  • 7.2 North America Mycoplasma Pneumoniae ELISA Kits Sales Quantity by Application (2020-2031)
  • 7.3 North America Mycoplasma Pneumoniae ELISA Kits Market Size by Country
    • 7.3.1 North America Mycoplasma Pneumoniae ELISA Kits Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Mycoplasma Pneumoniae ELISA Kits Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Mycoplasma Pneumoniae ELISA Kits Sales Quantity by Type (2020-2031)
  • 8.2 Europe Mycoplasma Pneumoniae ELISA Kits Sales Quantity by Application (2020-2031)
  • 8.3 Europe Mycoplasma Pneumoniae ELISA Kits Market Size by Country
    • 8.3.1 Europe Mycoplasma Pneumoniae ELISA Kits Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Mycoplasma Pneumoniae ELISA Kits Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Mycoplasma Pneumoniae ELISA Kits Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Mycoplasma Pneumoniae ELISA Kits Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Mycoplasma Pneumoniae ELISA Kits Market Size by Region
    • 9.3.1 Asia-Pacific Mycoplasma Pneumoniae ELISA Kits Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Mycoplasma Pneumoniae ELISA Kits Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Mycoplasma Pneumoniae ELISA Kits Sales Quantity by Type (2020-2031)
  • 10.2 South America Mycoplasma Pneumoniae ELISA Kits Sales Quantity by Application (2020-2031)
  • 10.3 South America Mycoplasma Pneumoniae ELISA Kits Market Size by Country
    • 10.3.1 South America Mycoplasma Pneumoniae ELISA Kits Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Mycoplasma Pneumoniae ELISA Kits Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Mycoplasma Pneumoniae ELISA Kits Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Mycoplasma Pneumoniae ELISA Kits Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Mycoplasma Pneumoniae ELISA Kits Market Size by Country
    • 11.3.1 Middle East & Africa Mycoplasma Pneumoniae ELISA Kits Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Mycoplasma Pneumoniae ELISA Kits Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Mycoplasma Pneumoniae ELISA Kits Market Drivers
  • 12.2 Mycoplasma Pneumoniae ELISA Kits Market Restraints
  • 12.3 Mycoplasma Pneumoniae ELISA Kits Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Mycoplasma Pneumoniae ELISA Kits and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Mycoplasma Pneumoniae ELISA Kits
  • 13.3 Mycoplasma Pneumoniae ELISA Kits Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Mycoplasma Pneumoniae ELISA Kits Typical Distributors
  • 14.3 Mycoplasma Pneumoniae ELISA Kits Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Mycoplasma Pneumoniae ELISA Kits market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    Mycoplasma pneumoniae ELISA Kits are diagnostic tools designed to detect the presence of Mycoplasma pneumoniae, a bacterium that can cause respiratory tract infections in humans. These kits employ Enzyme-ed Immunosorbent Assay (ELISA) technology to identify specific antibodies produced by the immune system in response to the infection or to detect the bacterium directly in clinical samples. The kits are valuable for healthcare professionals in diagnosing mycoplasmal pneumonia and guiding appropriate treatment. Mycoplasma pneumoniae ELISA Kits are accurate, sensitive, and widely used in clinical laboratories.
    The industry trend for Mycoplasma pneumoniae ELISA Kits is influenced by factors such as the increasing prevalence of respiratory infections, the growing awareness of mycoplasmal pneumonia, and the need for accurate diagnostic methods. Advances in ELISA technology continue to improve the sensitivity and specificity of these kits, making them more reliable for diagnosing Mycoplasma pneumoniae infections. Additionally, as healthcare systems focus on early detection and management of respiratory illnesses, the demand for Mycoplasma pneumonia ELISA Kits is expected to rise, contributing to the growth of the industry.
    This report is a detailed and comprehensive analysis for global Mycoplasma Pneumoniae ELISA Kits market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Mycoplasma Pneumoniae ELISA Kits market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Mycoplasma Pneumoniae ELISA Kits market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Mycoplasma Pneumoniae ELISA Kits market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Mycoplasma Pneumoniae ELISA Kits market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Mycoplasma Pneumoniae ELISA Kits
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Mycoplasma Pneumoniae ELISA Kits market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MyBioSource, BosterBio, Abcam, Novus Biologicals, CUSABIO Technology, Creative Diagnostics, United States Biological, Biorbyt, DEMEDITEC Diagnostics, Abnova Corporation, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Mycoplasma Pneumoniae ELISA Kits market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    IgG
    IgM
    Market segment by Application
    Laboratory
    Hospital
    Others
    Major players covered
    MyBioSource
    BosterBio
    Abcam
    Novus Biologicals
    CUSABIO Technology
    Creative Diagnostics
    United States Biological
    Biorbyt
    DEMEDITEC Diagnostics
    Abnova Corporation
    Abbexa
    Creative Biolabs
    IBL
    Aviva Systems Biology
    American Research Products
    Wuhan Fine Biotech
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Mycoplasma Pneumoniae ELISA Kits product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Mycoplasma Pneumoniae ELISA Kits, with price, sales quantity, revenue, and global market share of Mycoplasma Pneumoniae ELISA Kits from 2020 to 2025.
    Chapter 3, the Mycoplasma Pneumoniae ELISA Kits competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Mycoplasma Pneumoniae ELISA Kits breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Mycoplasma Pneumoniae ELISA Kits market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Mycoplasma Pneumoniae ELISA Kits.
    Chapter 14 and 15, to describe Mycoplasma Pneumoniae ELISA Kits sales channel, distributors, customers, research findings and conclusion.

    Buy now